Centenial Surgical Suture Ltd.
BSE: CSURGSU · Medical Equipment & Supplies · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹11 cr (FY26): borrowings are higher by ₹11 cr.
- Operating profit covered interest 0.7x in the last 12 months.
- Net loss in 4 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹71.25 on 2026-10-26: -43.0% from the 52-week high, +0.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 13 | 13 | 13 | 15 | 13 | 15 |
| EBITDA | 2 | 1 | 1 | 2 | 1 | 2 |
| OPM % | 15.6% | 9.5% | 10.3% | 10.3% | 7.5% | 14.2% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -1 | -0 | -0 | 0 | -2 | 1 |
| EPS (₹) | 3.24 | 0.11 | 0.03 | 0.40 | 6.34 | 2.01 |
| Revenue YoY | -5.5% | +18.5% | ||||
| Profit YoY | – | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 44 | 53 | 51 | 54 | 54 | 56 |
| EBITDA | 4 | 4 | 5 | 6 | 5 | 6 |
| Net profit | 1 | 1 | 1 | -1 | -2 | -1 |
| EPS (₹) | 1.72 | 2.43 | 3.11 | 4.01 | 6.04 | 8.78 |
| Revenue growth | +18.5% | -2.8% | +4.6% | +0.6% | – | |
| Profit growth | +58.7% | +13.0% | -229.2% | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +0.7% | – | – |
| Net profit | – | – | – |
| EPS | +35.5% | – | – |
| Share price | – | -25.1% (2y) | -34.6% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 31 | 29 |
| Borrowings | 12 | 11 |
| Cash & equivalents | 0 | 0 |
| Total assets | 85 | 80 |
| Fixed assets | 20 | 18 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 18 | 18 |
| Inventory | 43 | 41 |
| Payables | 7 | 7 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 14 | 4 |
| Cash from investing | -12 | -2 |
| Cash from financing | -2 | -2 |
| Capex | 11 | 2 |
| Free cash flow | 2 | 2 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -4.8% | -7.7% |
| ROCE % | 4.9% | 3.2% |
| Debtor days | 125 | 124 |
| Inventory days | 921 | 791 |
| Payable days | 152 | 146 |
| Cash conversion cycle (days) | 894 | 769 |
| Working capital days | 212 | 193 |
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CSURGSU | ₹26 cr | 8.1x | 0.9x | -4.9% | 5.7% | 10.7% | +0.7% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | CSURGSU |
| BSE code | 531380 |
| ISIN | INE405H01018 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.